Compare TTK HEALTHCARE with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE ABBOTT INDIA TTK HEALTHCARE/
ABBOTT INDIA
 
P/E (TTM) x 18.0 62.3 29.0% View Chart
P/BV x 1.2 18.5 6.5% View Chart
Dividend Yield % 1.3 0.4 343.1%  

Financials

 TTK HEALTHCARE   ABBOTT INDIA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
ABBOTT INDIA
Mar-19
TTK HEALTHCARE/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1,2158,834 13.8%   
Low Rs6105,458 11.2%   
Sales per share (Unadj.) Rs444.41,731.1 25.7%  
Earnings per share (Unadj.) Rs17.2211.9 8.1%  
Cash flow per share (Unadj.) Rs27.6219.9 12.6%  
Dividends per share (Unadj.) Rs5.0065.00 7.7%  
Dividend yield (eoy) %0.50.9 60.2%  
Book value per share (Unadj.) Rs177.9945.2 18.8%  
Shares outstanding (eoy) m14.1321.25 66.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.14.1 49.8%   
Avg P/E ratio x52.933.7 156.9%  
P/CF ratio (eoy) x33.032.5 101.6%  
Price / Book Value ratio x5.17.6 67.8%  
Dividend payout %29.030.7 94.5%   
Avg Mkt Cap Rs m12,894151,848 8.5%   
No. of employees `0002.33.5 66.3%   
Total wages/salary Rs m1,3074,356 30.0%   
Avg. sales/employee Rs Th2,715.710,555.5 25.7%   
Avg. wages/employee Rs Th565.31,249.9 45.2%   
Avg. net profit/employee Rs Th105.41,292.2 8.2%   
INCOME DATA
Net Sales Rs m6,27936,786 17.1%  
Other income Rs m781,133 6.8%   
Total revenues Rs m6,35637,919 16.8%   
Gross profit Rs m4966,047 8.2%  
Depreciation Rs m147169 86.7%   
Interest Rs m3423 150.2%   
Profit before tax Rs m3936,989 5.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1492,485 6.0%   
Profit after tax Rs m2444,503 5.4%  
Gross profit margin %7.916.4 48.0%  
Effective tax rate %37.935.6 106.7%   
Net profit margin %3.912.2 31.7%  
BALANCE SHEET DATA
Current assets Rs m2,71727,610 9.8%   
Current liabilities Rs m1,5718,569 18.3%   
Net working cap to sales %18.351.8 35.3%  
Current ratio x1.73.2 53.7%  
Inventory Days Days3260 53.4%  
Debtors Days Days4727 170.3%  
Net fixed assets Rs m9911,057 93.8%   
Share capital Rs m141213 66.5%   
"Free" reserves Rs m2,37319,873 11.9%   
Net worth Rs m2,51420,086 12.5%   
Long term debt Rs m30-   
Total assets Rs m4,15829,409 14.1%  
Interest coverage x12.6311.6 4.0%   
Debt to equity ratio x00-  
Sales to assets ratio x1.51.3 120.7%   
Return on assets %6.715.4 43.4%  
Return on equity %9.722.4 43.2%  
Return on capital %16.934.9 48.5%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31NA-   
Fx inflow Rs m225369 61.0%   
Fx outflow Rs m714,918 1.4%   
Net fx Rs m154-4,549 -3.4%   
CASH FLOW
From Operations Rs m1734,991 3.5%  
From Investments Rs m97-2,570 -3.8%  
From Financial Activity Rs m-307-1,428 21.5%  
Net Cashflow Rs m-38993 -3.8%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 3.7 7.9 46.8%  
FIIs % 5.2 0.1 5,200.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 17.1 150.9%  
Shareholders   12,723 18,270 69.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   GLENMARK PHARMA  UNICHEM LAB  DR. REDDYS LAB  DIVIS LABORATORIES  ALEMBIC LTD  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 173 Points Lower; IT and Realty Stocks Witness Selling(Closing)

Indian share markets witnessed selling pressure during closing hours today, tracking weakness in global markets owing to coronavirus outbreak.

Related Views on News

TORRENT PHARMA at All Time High; BSE HEALTHCARE Index Up 3.1% (Market Updates)

Apr 8, 2020 | Updated on Apr 8, 2020

TORRENT PHARMA share price has hit an all time high at Rs 2,509 (up 2.9%). The BSE HEALTHCARE Index is up by 3.1%. Among the top gainers in the BSE HEALTHCARE Index today are TORRENT PHARMA (up 2.9%) and ABBOTT INDIA (up 3.7%). The top losers include GSK PHARMA (down 0.3%) and FORTIS HEALTHCARE (down 0.6%).

ABBOTT INDIA at All Time High; BSE HEALTHCARE Index Up 1.3% (Market Updates)

Apr 8, 2020 | Updated on Apr 8, 2020

ABBOTT INDIA share price has hit an all time high at Rs 16,999 (up 1.7%). The BSE HEALTHCARE Index is up by 1.3%. Among the top gainers in the BSE HEALTHCARE Index today are ABBOTT INDIA (up 1.7%) and SANOFI INDIA (up 1.3%). The top losers include ASTRAZENECA PHARMA and AJANTA PHARMA (down 0.1%).

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

One Stock that is All Charged Up for the Post Coronavirus Rebound(The 5 Minute Wrapup)

Apr 1, 2020

A stock with strong moat is currently trading near 5-year lows.

The Insiders See a Buying Opportunity in These Smallcaps Amid Coronavirus Outbreak(Profit Hunter)

Mar 31, 2020

The promoters are buying these smallcaps amid the coronavirus outbreak.

A Safe Stock to Lockdown Now(The 5 Minute Wrapup)

Apr 2, 2020

The market crashc has made strong, established brands attractive. Here's a stock to make the most of this opportunity...

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Apr 8, 2020 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - DISHMAN PHARMA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS